by Eric Christianson | Jan 19, 2022 | Medication and Disease State Clinical Pearls For Pharmacists
Lasmiditan (Reyvow) is an agent that can be utilized for acute migraine treatment. It works slightly differently than triptans. While triptans target serotonin receptor subtypes 1B and 1D, lasmiditan targets serotonin receptor subtype 1F. The biggest reason that this...
by Eric Christianson | Dec 22, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Tricyclic antidepressants are still used in clinical practice. Their use has diminished over time as newer and generally safer medications have been invented, but you will see them occasionally. In my primarily geriatric practice, I would say that I see them a couple...
by Eric Christianson | Dec 19, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
I try to tackle questions that I receive periodically and someone asked me the other day, “In your experience, does amoxicillin/clavulanate cause more diarrhea than amoxicillin?” Amoxicillin and amoxicillin/clavulanate (Augmentin) can be used for numerous...
by Eric Christianson | Dec 12, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Bisphosphonates are frequently used in the management of osteoporosis. They are often the go-to agent for this condition. Below we provide a bisphosphonate comparison table and I also wanted to highlight some of the most important clinical pearls that we should teach...
by Eric Christianson | Dec 8, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
I encounter patients on a daily basis who are taking medications for urinary issues. Incontinence, frequency, BPH, and frequent UTIs are common problems in geriatrics that can lead to the use of medications. Here are some of my pet peeves with these issues. No One...
by Eric Christianson | Dec 5, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Selective Serotonin Reuptake Inhibitors are a mainstay in the management of depression and other mental health disorders. All SSRIs are not created equal and when I am reviewing a patient case, I make sure to look for specific things that may put a patient at risk for...
